Opko Health Incorporation operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Opko Health Incorporation with three other
companies in this sector in the United States:
Akorn, Inc.
(2016
sales of $1.12 billion
of which 94%
was Prescription Pharmaceuticals),
Indivior Plc
($1.06 billion
of which 100%
was Buprenorphine Based Drugs), and
Biomarin Pharmaceutical Inc
($1.12 billion
of which 32%
was Vimizim).

Sales Analysis.
During the year ended December of 2016, sales at
Opko Health Incorporation were $1.22 billion.
This
is
an
increase of 148.4%
versus 2015, when the company's sales were $491.74 million.